SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055653
Filing Date
2024-05-08
Accepted
2024-05-08 16:10:55
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-20240331.htm   iXBRL 10-Q 2146776
2 EX-10.1 dvax-ex10_1.htm EX-10.1 182790
3 EX-31.1 dvax-ex31_1.htm EX-31.1 14098
4 EX-31.2 dvax-ex31_2.htm EX-31.2 13818
5 EX-32.1 dvax-ex32_1.htm EX-32.1 8645
  Complete submission text file 0000950170-24-055653.txt   9810888

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dvax-20240331.xsd EX-101.SCH 1680523
76 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20240331_htm.xml XML 1671523
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 24926125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)